FDA approves ExpressMD Solutions’ health monitoring system

BERKELEY HEIGHTS, N.J. The Food and Drug Administration recently granted 510(k) marketing clearance to ExpressMD Solutions for its remote patient health monitoring system, the company announced Tuesday.

The Electronic House Call System is designed for use by healthcare professionals who manage patients with chronic conditions, such as heart disease, COPD/asthma and diabetes. Vital signs collected by the system’s connected peripheral devices include a patient’s weight, temperature, pulse and blood pressure, and other specific patient data such as blood glucose levels.

“Now that we have received FDA approval for the ExpressMD telehealth solution, Electronic House Call, we can move forward with the next phase of our sales and marketing strategy, and selling systems into the market,” stated Ronald Mills, ExpressMD Solutions managing director. “Part of this effort will be supported through a non-exclusive distribution agreement already in place with Cyntrist, which covers the Southeastern U.S. region. We believe that remote patient monitoring has the power to effectively change the landscape of the patient care model by lowering costs and improving patient care.”

The Electronic House Call monitor securely transmits a patient’s vital signs to its data center and makes that data available to a licensed care provider via a secure Web site. By remotely receiving patient data daily, licensed care providers can adjust treatment accordingly and provide an enhanced level of care.

ExpressMD Solutions is a joint venture formed by Authentidate Holding and EncounterCare Solutions on the delivery of remote patient monitoring telehealth systems and services.